WASHINGTON – The upcoming National Prescription Drug Take Back Day scheduled for Saturday, April 25, 2020 is postponed due to the ongoing coronavirus (COVID-19) pandemic. DEA will reschedule Take Back Day for a date shortly after the health crisis recedes and national emergency guidelines are lifted. The health and safety...

WASHINGTON – Former president of Venezuela Nicolás Maduro Moros, Venezuela’s vice president for the economy, Venezuela’s minister of defense, and Venezuela’s chief supreme court justice are among those charged in New York City; Washington, D.C.; and Miami, along with current and former Venezuelan government officials and two Fuerzas Armadas Revolucionarias...

WASHINGTON – Today, the Drug Enforcement Administration and the Department of Justice announced action to further expand opportunities for scientific and medical research on marijuana in the United States. The Notice of Proposed Rulemaking provides details on the proposed process and was filed for public inspection today, March 20. The...

WASHINGTON – During the unprecedented health emergency caused by the ongoing coronavirus (COVID-19) pandemic, the health and safety of our communities is DEA’s top priority. DEA is responding appropriately to ensure Americans continue to have access to necessary medications and controlled substances. DEA’s efforts include supporting prescribing practices that limit...

WASHINGTON – The Justice Department and the Drug Enforcement Administration today announced the results of Project Python, a DEA-led interagency operation encompassing all global investigations and related disruption activities targeting the Cártel de Jalisco Nueva Generación (CJNG). This announcement marks the successful conclusion of six months of investigative and enforcement...

WASHINGTON – A dual U.S.-Mexican citizen had her initial appearance in federal court in the District of Columbia Wednesday on charges related to her alleged involvement in five business entities designated by the Department of Treasury’s Office of Foreign Asset Control (OFAC) as providing material support to the international narcotics...

WASHINGTON – The Drug Enforcement Administration today announced an important step to improve access to medication assisted treatment, especially in rural areas where those suffering with opioid use disorder may have limited treatment options. “Thankfully, prescription opioid overdose deaths have declined more than 13 percent, but thousands of Americans still...

WASHINGTON – Drug Enforcement Administration Acting Administrator Uttam Dhillon today announced that the DEA will direct enforcement resources to methamphetamine “transportation hubs” — areas where methamphetamine is often trafficked in bulk and then distributed across the country. While continuing to focus on stopping drugs being smuggled across the border, DEA’s...

The DEA is grateful for the President’s leadership on this issue as we continue our fight to combat the nation’s opioid epidemic. This legislation is critical to DEA’s mission - to keep Americans safe by keeping these dangerous drugs off the streets. We look forward to working with our partners...

DETROIT – Drug Enforcement Administration Acting Administrator Uttam Dhillon today announced the publication of the 2019 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. “This year’s report illustrates a shifting drug landscape in...